Nationwide Fund Advisors Insmed Inc Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$26.43 - $31.78 $1.09 Million - $1.31 Million	-41,302 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$11.61 - $31.21 $80,654 - $216,815	6,947 Added 20.22%	41,302 $1.29 Million
Q2 2017 Aug 10, 2017	BUY	N/A	34,355	34,355 $590,000

447

170M

5.79M

5.18M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.88B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.